News Image

ADMA BIOLOGICS INC (NASDAQ:ADMA) - A Strong Growth Candidate Meeting Minervini's Criteria

By Mill Chart

Last update: Jun 13, 2025

ADMA BIOLOGICS INC (NASDAQ:ADMA) has been identified as a high-growth momentum stock that aligns with Mark Minervini’s Trend Template. The company, a biopharmaceutical firm specializing in plasma-derived biologics, demonstrates strong technical and fundamental characteristics that make it a compelling candidate for growth-focused investors.

ADMA stock chart

Why ADMA Fits the Minervini Trend Template

Minervini’s strategy focuses on stocks with strong upward momentum, confirmed by key technical indicators. ADMA meets these criteria:

  • Price Above Key Moving Averages: The stock trades above its 50-day ($20.82), 150-day ($19.08), and 200-day ($18.78) moving averages, indicating sustained bullish momentum.
  • Rising Moving Averages: Both the 150-day and 200-day MAs are trending upward, reinforcing long-term strength.
  • Relative Strength: With a ChartMill Relative Strength (CRS) score of 95.42, ADMA outperforms 95% of stocks, a key trait for Minervini-style leaders.
  • Price Performance: The stock is up 103% over the past year and is trading within 16% of its 52-week high ($25.67), showing strong momentum.

High Growth Fundamentals

ADMA’s financials reflect accelerating growth, a critical factor for high-growth investors:

  • Earnings Growth: EPS surged 2,750% year-over-year (TTM), with recent quarterly growth of 37.5%.
  • Revenue Growth: Sales increased 62.2% (TTM), with consistent quarterly growth above 40%.
  • Profit Margins: The company reported a trailing twelve-month profit margin of 46.35%, a significant improvement from prior years.
  • Estimate Revisions: While next-year EPS estimates have seen slight downward revisions (-4.69%), revenue forecasts remain positive (+5.69%).

Technical Outlook

ADMA’s technical rating of 10/10 highlights its strong trend, though the current setup rating of 5 suggests waiting for a consolidation before entry. Key support levels are found at $20.18-$20.31 and $19.20, providing potential downside protection.

Our High Growth Momentum + Trend Template screener lists more stocks with similar growth and momentum traits.

For a deeper technical analysis, review the full ADMA technical report.

Disclaimer

This is not investment advice. Always conduct your own research and consider risk management before making investment decisions.

ADMA BIOLOGICS INC

NASDAQ:ADMA (8/29/2025, 6:08:43 PM)

After market: 17.26 0 (0%)

17.26

-0.12 (-0.69%)



Find more stocks in the Stock Screener

Follow ChartMill for more